
Ashlan J. Kunz Coyne
@ashlan_kunz
Asst Professor of Translational Research @UK_COP
ID: 4786317557
12-01-2016 17:46:13
900 Tweet
328 Takipçi
199 Takip Edilen

🚨 New Publication Alert Science Magazine Translational Medicine has featured a new study led by Dr. Caroline Geisler, assistant professor at University of Kentucky College of Pharmacy, on a novel brain-targeting approach to obesity treatment. Current weight loss drugs like GLP-1 receptor agonists (e.g.,




University of Kentucky College of Pharmacy researcher Caroline Geisler and her team recently explored whether a signaling system in the brain could be targeted to achieve weight loss and blood sugar control without triggering the side effects that often accompany popular GLP-1 medications. research.uky.edu/news/qa-caroli…


New Pub Alert 🚨 Dr. Kunz Coyne (Ashlan J. Kunz Coyne) and the Kunz Coyne Lab are authors of a newly published study in Open Forum Infectious Diseases (OFID), the journal of the Infectious Diseases Society of America (IDSA), titled “Propensity-Matched Comparison of Timely vs. Delayed



A new study from University of Kentucky Martin-Gatton CAFE reveals that antibiotic resistance in cattle-associated bacteria could have far-reaching implications for human, animal and environmental health. research.uky.edu/news/uk-study-…


New episode alert! 7 PM Antibiotics: What’s New 💊🧫 From cefepime–enmetazobactam to sulopenem and tebipenem Ashlan J. Kunz Coyne joins me to unpack the latest antibiotics, share key clinical insights, and talk stewardship strategies for tackling resistance. #letstalkmicro

Had a blast talking new antimicrobial with Letstalkmicro ! 🧫

Happy Friday! 🎉 A new episode just dropped: ESBL, UTIs & new antibiotics 💊🦠 What’s new? 🎙️ Link in comments. #microbiology #podcast #ESBL #UTI #antibiotics Ashlan J. Kunz Coyne



Episose alert: Why wait 24 hours for AST? ⏳ Drs. Osborn & Dien Bard discuss how early growth isolates could provide faster AST results—without extra cost or equipment. 🎙️ Episode: Early Growth, Faster Answers: Rethinking AST 7 PM EST Lucas Osborn, PhD, D(ABMM) #letstakmicro #podcast

🎉 Happy Friday! The latest episode is out! Faster AST results—18 hours sooner ⏱️ Drs. Jenn Dien Bard & Lucas Osborn explain early growth AST & what it means for labs + patients. 🎙️ Listen here: directory.libsyn.com/episode/index/… Lucas Osborn, PhD, D(ABMM)


💊 Sulopenem FDA approval: for adult women with uncomplicated UTIs (E. coli, K. pneumoniae, P. mirabilis) — only when other options are limited. 🎙️ Hear Dr. Ashlan Kunz Coyne explain more in Let’s Talk Micro. 👉 asm.org/podcasts/lets-… Ashlan J. Kunz Coyne


